Archive for May 11th, 2012

Pipeline updates for YMI OREX IMMU BDSI FOLD

May 11, 2012 No Comments by

YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM) provided an update today on CYT387 for the treatment of myelofibrosis. It intends to initiate its Phase 3 trial during 2H 2012. By the end of 2012 both final data from its Phase 1/2 Core trial and interim data from the Phase 1/2 Extension trial are expected to be reported. Interim […]

Daily News Read more